USP <661> Plastics Testing

USP <661> Plastic Packaging Systems Compliance Requirements

Updated: Jun 2025QTC Global Compliance TeamRegulatory reference content

Interpreting current USP standards for plastics, detailing USP <661.1> materials characterization and USP <661.2> packaging system test metrics.

Key answer

The U.S. Pharmacopeia separates plastic compliance into two stages. USP <661.1> tests raw polymer materials/resins, requiring FTIR ID, DSC thermal scans, TOC tests, and heavy metal titrations. USP <661.2> tests completed container/packaging systems, focusing on physicochemical indicators (non-volatile residue, UV absorbance, pH shift) and bio-safety (USP <87> cytotoxicity).

Core Physicochemical Specs for USP <661.1> Resins

Resin variability shifts finished container compatibility. Suppliers should submit pharmacopeial testing data.

  • FTIR spectroscopy: capturing fingerprint scans, peak distributions matching the standard reference resin
  • Total Organic Carbon (TOC): measuring soluble organic carbon in water extracts to limit leachables
  • Buffering capacity: preventing packaging extracts from altering formulation pH stability

FAQ

What is USP <87> Cytotoxicity testing?+

USP <87> is an in vitro biological evaluation. The packaging extract is placed on mammalian cell cultures (such as L-929) via agar diffusion or direct contact. Cells are incubated for 24-48 hours and checked for lysis and malformation to evaluate bio-toxicity.

Next steps

If this topic applies to your product, facility, or supply chain requirement, start by confirming the target market, customer-required standard, existing documents, audit history, and expected timeline.